Reply to F. Gelsomino et al

Affiliations

Comment

Scott A Laurie et al. J Clin Oncol. 2013.

. 2013 Sep 10;31(26):3293-4.

doi: 10.1200/JCO.2013.50.8705. Epub 2013 Aug 12.

¹ The Ottawa Hospital Cancer Centre, the University of Ottawa, Ottawa, Ontario, Canada.

No abstract available

Comment on

Role of epidermal growth factor receptor inhibitors in epidermal growth factor receptor wild-type non-small-cell lung cancer.
Laurie SA, Goss GD. Laurie SA, et al. J Clin Oncol. 2013 Mar 10;31(8):1061-9. doi: 10.1200/JCO.2012.43.4522. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401452 Review.
Epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with EGFR wild-type non-small-cell lung cancer: the never-ending story.
Gelsomino F, Agustoni F, Niger M, Valota M, Haspinger ER. Gelsomino F, et al. J Clin Oncol. 2013 Sep 10;31(26):3291-3. doi: 10.1200/JCO.2013.50.2617. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23940223 No abstract available.